Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
CD ROMAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Optimizing Treatment for Bone Metastases in Advanced Cancers 2011

The Assessment Group, Oct 2011, Pages: 27


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Understand current practice patterns related to bone metastases in patients with advanced cancers. Patient specific unfolding case scenarios presented to 174 high-prescribing oncologists on the treatment of bones metastases in patients with advanced stages of cancer including breast, renal cell carcinoma, and prostate. The survey was presented for their responses on clinical decisions. Oncologists were asked to respond to open-ended questions concerning their choices of treatment regimens, factors that influence their decisions, and barriers to optimal patient management. The survey was administered electronically by Qualtrics survey software between December 15, 2010 and March 31, 2011. Patient progression reveals decisions in treatment throughout patient stages.

Patient case highlights:

- ER/PR positive HER2/neu negative metastatic breast cancer with bone metastases
- Metastatic breast cancer with bone metastases in a patient with multiple comorbidities
- Metastatic clear cell carcinoma with lytic bone lesions
- Patient with increased PSA and adenocarcinoma
- Patient with asymptomatic castration-resistant metastatic disease
- Symptomatic prostate disease in an elderly patient with Gleason’s 5+5 and widespread metastatic disease

Treatment decisions for advanced stages of cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.

This report allows you to:

- Understand what occurs in physician practice and why
- See the variations in practice patterns
- Understand where treatments fit in physician decisions
- Gain actionable data for marketing strategies


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds